Overview
The Functional, Molecular & Translational Neuroimaging Lab was founded in 2005 to integrate functional, structural and molecular neuroimaging expertise in clinical neurosciences in vivo. The objective was to establish an open interdisciplinary platform beyond department structures to support the knowledge transfer in neuroimaging methods within the MUW and between cooperating partners. This open network is a meeting place for research people and clinicans fascinated by the combination of promising new neuroimaging techniques and methods:
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Functional Magnetic Resonance Imaging (fMRI, phfMRI)
- Structural Magnetic Resonance Imaging (MRI, VBM)
- Molecular and Functional Imaging of Neurogenetics (GenNI)
→ JOIN the NEUROIMAGING NETWORK
News
Serotonin-1A Receptor Distribution |
||
|
|
||
| Watch Video in new Window |
|
|
![]() |
|
| Watch Video in new Window |
Upcoming Events with presentations of our group
- ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe
Georg Kranz, 15-18 March 2012
European College of Neuropsychopharmacology Nice, France - PET in imaging genetics.
Lanzenberger R, Jan 17 2012
8th Annual International Imaging Genetics Conference, University of California, The Beckman Center of the National Academy of Sciences in Irvine, 16-17 Jan. 2012, California, USA
Lanzenberger R. joined the Editorial Board of The International Journal of Neuropsychopharmacology (2010 IF 4.699), the official scientific journal of the Collegium Internationale Neuro- Psychopharmacologicum (CINP)
Lanzenberger R. joined the Editorial Board of European Neuropsychopharmacology (2010 IF 4.201), the official scientific journal of the European College of Neuropsychopharmacology (ECNP)
Lanzenberger R. joined the Editorial Board of the World Journal of Biological Psychiatry (2010 IF 2.048)







